Clinical Trials

Groupe PARIMA supports clinical trials with a one-site model that connects GMP manufacturing, integrated analytical services, and packaging execution. Direct access to our teams helps keep decisions fast and clinical supply consistent as timelines shift.

AdobeStock_1862304399 1
Release With Control

Clinical supply is where execution meets timelines.

Groupe PARIMA supports clinical supply through an integrated model that connects GMP manufacturing, in-house analytical services, and packaging execution in one workflow. With direct access to scientific and project teams, we help sponsors maintain control over quality, documentation, and packaging requirements as clinical timelines move.

A partner aligned with your clinical trial requirements.

Clinical programs change. Volumes shift, presentation evolves, and timelines compress. Groupe PARIMA works as an extension of your team with transparent coordination, direct access to experts, and packaging and testing capabilities that support release for clinical use.

Keep teams aligned

Direct access to scientific teams and dedicated project management support clear decisions and steady execution as trial needs evolve.

Release with confidence

GMP release testing and documentation are supported by in-house analytical capabilities, including chemical and microbiology testing used to verify finished product quality before clinical use.

Manage packaging and distribution complexity

Provide primary and secondary packaging options, including kit configurations and cold‑chain handling, supported by audited transport and 3PL partnerships.

A clinical‑supply model built to reduce friction

Clinical trials benefit from partners that can connect manufacturing, testing, packaging, and release activities without unnecessary handoffs. Groupe PARIMA’s integrated approach supports clinical execution with direct collaboration, adaptable packaging formats, and in‑house laboratory capabilities that help confirm product quality before release for trial use.

01
Image (2)

Integrated packaging for clinical needs

Primary and secondary packaging capabilities support clinical formats, including kit assembly and custom configurations when needed.

02
Image (3)

Cold‑chain and sensitive product support

Packaging workflows include cold‑chain handling and options that accommodate light‑ or oxygen‑sensitive products.

03
Image (9)

In‑house testing that supports release

A GMP‑certified in‑house laboratory supports method work and routine analysis to help verify finished product quality before clinical use.

04
Image (10)

End‑to‑end support services around clinical supply

Support services include API and packaging sourcing, GMP release documentation, and audited transport and 3PL partnerships.

Services

Phase III requires repeatable clinical lots, validated processes, and documentation that supports regulatory filings. We align execution and data generation so the program stays consistent as expectations increase.

01
Layer_1-1
Product Development

Support process, cleaning, and packaging validation with documentation aligned to late-stage needs.

02
Icons-1
Analytical Services

Deliver method validation plus microbiology and ICH-aligned stability daa to support submissions.

03
Icons (1)-1
Manufacturing & Packaging

Run late-stage GMP lots and complete packaging, labeling, and serialization on-site to reduce transfer risk.

We help de‑risk clinical execution by connecting GMP manufacturing, in‑house testing, packaging, and release support under one integrated model.

Resources

These resources demystify how CDMOs support clinical trials and what to consider when planning clinical materials, packaging formats, and release requirements.

Groupe PARIMA
2026/04/27
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
Groupe PARIMA
2026/03/18
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Groupe PARIMA
2025/10/23
Topical 101: A Guide to Complex Dermatology Formulation Development
Groupe PARIMA
2026/04/27
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
Groupe PARIMA
2026/03/18
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Groupe PARIMA
2025/10/23
Topical 101: A Guide to Complex Dermatology Formulation Development

Contact us

Discuss your clinical 
Trial plan

Tell us where your trial program stands, and we will help you evaluate the right next step for GMP clinical manufacturing.